DEMEGEN INC
10QSB, EX-27, 2000-08-11
MEDICAL LABORATORIES
Previous: DEMEGEN INC, 10QSB, 2000-08-11
Next: TRANSDIGM INC /FA/, 10-Q, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE INTERIM
UNAUDITED BALANCE SHEET AT JUNE 30, 2000 AND THE RELATED STATEMENT OF OPERATIONS
FOR THE NINE MONTHS ENDED JUNE 30, 2000.
</LEGEND>
<MULTIPLIER> 1

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                       2,229,551
<SECURITIES>                                         0
<RECEIVABLES>                                   60,759
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             2,560,898
<PP&E>                                         363,625
<DEPRECIATION>                                 193,245
<TOTAL-ASSETS>                               2,923,996
<CURRENT-LIABILITIES>                          390,339
<BONDS>                                        471,796
                        1,966,912
                                          0
<COMMON>                                        32,305
<OTHER-SE>                                      62,644
<TOTAL-LIABILITY-AND-EQUITY>                 2,923,996
<SALES>                                              0
<TOTAL-REVENUES>                               708,347
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             1,858,957
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               9,825
<INCOME-PRETAX>                            (1,160,435)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,160,435)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,160,435)
<EPS-BASIC>                                     (0.05)
<EPS-DILUTED>                                   (0.05)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission